Literature DB >> 24072723

Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study.

Andreas Lossius1, Trond Riise, Maura Pugliatti, Kjetil Bjørnevik, Ilaria Casetta, Jelena Drulovic, Enrico Granieri, Margitta T Kampman, Anne-Marie Landtblom, Klaus Lauer, Sandra Magalhaes, Kjell-Morten Myhr, Tatjana Pekmezovic, Kristin Wesnes, Christina Wolfson, Trygve Holmøy.   

Abstract

BACKGROUND: Seasonal fluctuations in solar radiation and vitamin D levels could modulate the immune response against Epstein-Barr virus (EBV) infection and influence the subsequent risk of multiple sclerosis (MS).
METHODS: Altogether 1660 MS patients and 3050 controls from Norway and Italy participating in the multinational case-control study of Environmental Factors In Multiple Sclerosis (EnvIMS) reported season of past infectious mononucleosis (IM).
RESULTS: IM was generally reported more frequently in Norway (p=0.002), but was associated with MS to a similar degree in Norway (odds ratio (OR) 2.12, 95% confidence interval (CI) 1.64-2.73) and Italy (OR 1.72, 95% CI 1.17-2.52). For all participants, there was a higher reported frequency of IM during spring compared to fall (p<0.0005). Stratified by season of IM, the ORs for MS were 1.58 in spring (95% CI 1.08-2.31), 2.26 in summer (95% CI 1.46-3.51), 2.86 in fall (95% CI 1.69-4.85) and 2.30 in winter (95% CI 1.45-3.66).
CONCLUSIONS: IM is associated with MS independently of season, and the association is not stronger for IM during spring, when vitamin D levels reach nadir. The distribution of IM may point towards a correlation with solar radiation or other factors with a similar latitudinal and seasonal variation.

Entities:  

Keywords:  Epstein-Barr virus; Multiple sclerosis; interaction; latitude; seasons; vitamin D

Mesh:

Substances:

Year:  2013        PMID: 24072723     DOI: 10.1177/1352458513505693

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study.

Authors:  Giammario Ragnedda; Stefania Leoni; Maria Parpinel; Ilaria Casetta; Trond Riise; Kjell-Morten Myhr; Christina Wolfson; Maura Pugliatti
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

Review 2.  Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease.

Authors:  Colleen Elizabeth Hayes; Shane L Hubler; Jerott R Moore; Lauren E Barta; Corinne E Praska; Faye E Nashold
Journal:  Front Immunol       Date:  2015-03-18       Impact factor: 7.561

3.  Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Authors:  Kjetil Bjørnevik; Trond Riise; Marianna Cortese; Trygve Holmøy; Margitta T Kampman; Sandra Magalhaes; Kjell-Morten Myhr; Christina Wolfson; Maura Pugliatti
Journal:  Mult Scler       Date:  2015-05-26       Impact factor: 6.312

4.  Breastfeeding is associated with reduced risk of multiple sclerosis in males, predominantly among HLA-DRB1*15:01 carriers.

Authors:  A K Hedström; C Adams; X Shao; C Schaefer; T Olsson; L F Barcellos; L Alfredsson
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-06-01

Review 5.  The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2016-01-08

6.  Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease.

Authors:  Kine Edvardsen; Alexander Hellesen; Eystein S Husebye; Eirik Bratland
Journal:  J Transl Med       Date:  2016-03-09       Impact factor: 5.531

7.  Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo.

Authors:  Yakov Lomakin; Georgii Pavlovich Arapidi; Alexander Chernov; Rustam Ziganshin; Evgenii Tcyganov; Irina Lyadova; Ivan Olegovich Butenko; Maria Osetrova; Natalia Ponomarenko; Georgy Telegin; Vadim Markovich Govorun; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2017-07-06       Impact factor: 7.561

Review 8.  Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives.

Authors:  Christina Tryfonos; Maria Mantzorou; Dimitris Fotiou; Michael Vrizas; Konstantinos Vadikolias; Eleni Pavlidou; Constantinos Giaginis
Journal:  Medicines (Basel)       Date:  2019-09-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.